Medtronic reported Q4 2024 sales of $8.59 billion, with 0.5% reported and 5.4% organic revenue growth. Dividend increased to $0.70 per share. FY 2025 EPS guidance is $5.40-$5.50.
Heart disease is the leading cause of death for women, but a new study showed 65 percent of women who have high risk factors, are not even referred to specialists. The top doctors in the field admit big changes need to happen fast before more women fall through the cracks.
Medtronic employees report more layoffs massdevice.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from massdevice.com Daily Mail and Mail on Sunday newspapers.
Press Release Thubrikar Aortic Valve, Inc. today announced successful results in the first two patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV™) using the new Precision 2™ Delivery Catheter. Interventional Cardiologist and TAVI-1 Study…